<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03683875</url>
  </required_header>
  <id_info>
    <org_study_id>ECO-ELA</org_study_id>
    <nct_id>NCT03683875</nct_id>
  </id_info>
  <brief_title>Ultrasonography of the Neuromuscular Degeneration Behavior in Amyotrophic Lateral Sclerosis</brief_title>
  <official_title>Ultrasonography of the Neuromuscular Degeneration Behavior in ALS: a Longitudinal Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Santa Lucia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad de Murcia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario Santa Lucia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amyotrophic Lateral Sclerosis (ALS) is a progressive and fatal neurological disease.

      An exhaustive and frequent clinical evaluation can lead to establish an adequate and early
      treatment of the consequences of its evolution.

      Objectives.

        1. To evaluate the evolution of diaphragmatic and peripheral neuromuscular degeneration by
           ultrasound examination in patients with ALS and to establish possible evolution
           patterns.

        2. To verify the relationship between the degenerative peripheral and diaphragmatic
           neuromuscular changes evaluated by ultrasonography and changes in clinical scales
           frequently used.

        3. To compare the ultrasonographic features of subjects with ALS and a sample of healthy
           subjects Methods. A longitudinal observational study in a consecutive sample of patients
           diagnosed with ALS will be realized. All the patients will be examined 3 times, with an
           interval of at least 3 months between tests. Bilateral and cross sectional
           ultrasonography of several peripheral muscles and diaphragm will be performed at rest
           and during muscle contraction. All the images will be processed and analyzed for
           obtaining morphometric variables (muscle thickness) and textural ones (echogenic
           variation, entropy, homogeneity, textural contrast and correlation). Frequency of
           twitches will be also recorded in peripheral muscles.Also clinical features will be
           noted, every time of the 3 exams, from Revised Amyotrophic Lateral Sclerosis Functional
           Rating Scale (ALSFRS-r), British Medical Council Research Scale(MRC), and routine
           pulmonary tests.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>Measuring thickness in peripheral muscles.</measure>
    <time_frame>3 months</time_frame>
    <description>These measurements will be carried out in the biceps brachialis, forearm flexors, thenar eminence muscle, quadriceps and tibialis anterior which will be compared between patient with ALS and control group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring echointensity and in peripheral muscles.</measure>
    <time_frame>3 months</time_frame>
    <description>These measurements will be carried out in the biceps brachialis, forearm flexors, thenar eminence muscle, quadriceps and tibialis anterior which will be compared between patient with ALS and control group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring sonoelastography in peripheral muscles.</measure>
    <time_frame>3 months</time_frame>
    <description>These measurements will be carried out in the biceps brachialis, forearm flexors, thenar eminence muscle, quadriceps and tibialis anterior which will be compared between patient with ALS and control group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thickness Fraction of the Diaphragm in ALS patients and control group.</measure>
    <time_frame>3 months</time_frame>
    <description>It is calculated as the difference between thickness at end inspiration and end expiration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diaphragmatic Excursion (quiet and forced) of the Diaphragm in ALS patients and control group</measure>
    <time_frame>3 months</time_frame>
    <description>Displacement of the right diaphragm dome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement muscle fasciculations</measure>
    <time_frame>3 months</time_frame>
    <description>Each peripheral muscle will be screened during 30 seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement muscle strength</measure>
    <time_frame>3 months</time_frame>
    <description>Graded on the medical research council scale. This scale grades muscle power on a scale of 0 to 5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-r)</measure>
    <time_frame>3 months</time_frame>
    <description>Questionnaire with 12 items with a score from 0 to 4 each item. These 12 questions are about: Speech, Swallowing, Handwriting, Cutting food and handling,utensils,Dressing and hygiene,Turning in bed and adjusting bed clothes, Walking, Climbing stairs, Dyspnea, Orthopnea and Respiratory insufficiency. This Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measuring Forced Vital Capacity</measure>
    <time_frame>3 months</time_frame>
    <description>This volume expressed in liters will be measured in supine and seated positions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Inspiratory Pressure (MIP)</measure>
    <time_frame>3 months</time_frame>
    <description>Measure of the strength of inspiratory muscles expressed in centimeters of water, is the highest mouth pressure sustained for 1 s during a maximum inspiratory effort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sniff- nasal inspiratory pressure (SNIP)</measure>
    <time_frame>3 months</time_frame>
    <description>It consists of measuring nasal pressure in an occluded nostril during a maximal sniff performed through the contralateral nostril, expressed in centimeters of water</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Cough Flow (PCF)</measure>
    <time_frame>3 months</time_frame>
    <description>Maximal peak cough flow expressed in liters per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial Pressure of Carbon Dioxide in Arterial Blood (PaCO2)</measure>
    <time_frame>3 months</time_frame>
    <description>Obtained by a radial arterial blood sample and expressed in millimeters of mercury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative time percentage with SpO2 under 90% (CT90)</measure>
    <time_frame>3 months</time_frame>
    <description>SpO2 is an estimate of arterial oxygen saturation expressed in percentage under 90% obtained from a nocturnal oximetry</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with Amyotrophic Lateral Sclerosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Definite ALS

        Exclusion Criteria:

          -  Primary Lateral Sclerosis (PLS)

          -  Other forms of motor neuron disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Tomás Ríos Cortés</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOSPITAL GENERAL UNIVERSITARIO SANTA LUCIA - SERVICIO MURCIANO DE SALUD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonio Tomás Ríos Cortés</last_name>
    <phone>+34968128600</phone>
    <phone_ext>950364</phone_ext>
    <email>a.riosfisio@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital General Universitario Santa Lucia</name>
      <address>
        <city>Cartagena</city>
        <state>Murcia</state>
        <zip>30202</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Tomás Ríos-Cortés</last_name>
      <email>a.riosfisio@gmail.com</email>
    </contact>
    <contact_backup>
      <phone>+34968128600</phone>
    </contact_backup>
    <investigator>
      <last_name>María Elena Del Baño-Aledo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacinto Martínez-Payá</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eva Fages-Caravaca</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pedro García-Torres</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Mayans D, Cartwright MS, Walker FO. Neuromuscular ultrasonography: quantifying muscle and nerve measurements. Phys Med Rehabil Clin N Am. 2012 Feb;23(1):133-48, xii. doi: 10.1016/j.pmr.2011.11.009. Epub 2011 Dec 9. Review.</citation>
    <PMID>22239880</PMID>
  </reference>
  <reference>
    <citation>Arts IMP, Overeem S, Pillen S, Jurgen Schelhaas H, Zwarts MJ. Muscle changes in amyotrophic lateral sclerosis: a longitudinal ultrasonography study. Clin Neurophysiol. 2011 Mar;122(3):623-628. doi: 10.1016/j.clinph.2010.07.023.</citation>
    <PMID>20810308</PMID>
  </reference>
  <reference>
    <citation>Arts IM, Overeem S, Pillen S, Kleine BU, Boekestein WA, Zwarts MJ, Jurgen Schelhaas H. Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis. Clin Neurophysiol. 2012 Aug;123(8):1662-7. doi: 10.1016/j.clinph.2011.11.262. Epub 2012 Jan 13.</citation>
    <PMID>22244867</PMID>
  </reference>
  <reference>
    <citation>Arts IM, Overeem S, Pillen S, Schelhaas HJ, Zwarts MJ. Muscle ultrasonography to predict survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011 May;82(5):552-4. doi: 10.1136/jnnp.2009.200519. Epub 2010 Apr 14.</citation>
    <PMID>20392981</PMID>
  </reference>
  <reference>
    <citation>Arts IM, van Rooij FG, Overeem S, Pillen S, Janssen HM, Schelhaas HJ, Zwarts MJ. Quantitative muscle ultrasonography in amyotrophic lateral sclerosis. Ultrasound Med Biol. 2008 Mar;34(3):354-61. Epub 2007 Oct 26.</citation>
    <PMID>17964067</PMID>
  </reference>
  <reference>
    <citation>Arts IM, Pillen S, Schelhaas HJ, Overeem S, Zwarts MJ. Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve. 2010 Jan;41(1):32-41. doi: 10.1002/mus.21458.</citation>
    <PMID>19722256</PMID>
  </reference>
  <reference>
    <citation>Schreiber S, Abdulla S, Debska-Vielhaber G, Machts J, Dannhardt-Stieger V, Feistner H, Oldag A, Goertler M, Petri S, Kollewe K, Kropf S, Schreiber F, Heinze HJ, Dengler R, Nestor PJ, Vielhaber S. Peripheral nerve ultrasound in amyotrophic lateral sclerosis phenotypes. Muscle Nerve. 2015 May;51(5):669-75. doi: 10.1002/mus.24431. Epub 2015 Mar 14.</citation>
    <PMID>25155020</PMID>
  </reference>
  <reference>
    <citation>Cartwright MS, Walker FO, Griffin LP, Caress JB. Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis. Muscle Nerve. 2011 Sep;44(3):346-51. doi: 10.1002/mus.22035. Epub 2011 Aug 3.</citation>
    <PMID>21815172</PMID>
  </reference>
  <reference>
    <citation>Martínez-Payá JJ, Del Baño-Aledo ME, Ríos-Díaz J, Tembl-Ferrairó JI, Vázquez-Costa JF, Medina-Mirapeix F. Muscular Echovariation: A New Biomarker in Amyotrophic Lateral Sclerosis. Ultrasound Med Biol. 2017 Jun;43(6):1153-1162. doi: 10.1016/j.ultrasmedbio.2017.02.002. Epub 2017 Apr 8.</citation>
    <PMID>28395965</PMID>
  </reference>
  <reference>
    <citation>Martínez-Payá JJ, Ríos-Díaz J, Del Baño-Aledo ME, Tembl-Ferrairó JI, Vazquez-Costa JF, Medina-Mirapeix F. Quantitative Muscle Ultrasonography Using Textural Analysis in Amyotrophic Lateral Sclerosis. Ultrason Imaging. 2017 Nov;39(6):357-368. doi: 10.1177/0161734617711370. Epub 2017 May 28.</citation>
    <PMID>28553752</PMID>
  </reference>
  <reference>
    <citation>Hiwatani Y, Sakata M, Miwa H. Ultrasonography of the diaphragm in amyotrophic lateral sclerosis: clinical significance in assessment of respiratory functions. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Mar;14(2):127-31. doi: 10.3109/17482968.2012.729595. Epub 2012 Oct 30.</citation>
    <PMID>23110443</PMID>
  </reference>
  <reference>
    <citation>Pinto S, Alves P, Pimentel B, Swash M, de Carvalho M. Ultrasound for assessment of diaphragm in ALS. Clin Neurophysiol. 2016 Jan;127(1):892-897. doi: 10.1016/j.clinph.2015.03.024. Epub 2015 Apr 25.</citation>
    <PMID>25971723</PMID>
  </reference>
  <reference>
    <citation>Fantini R, Mandrioli J, Zona S, Antenora F, Iattoni A, Monelli M, Fini N, Tonelli R, Clini E, Marchioni A. Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. Respirology. 2016 Jul;21(5):932-8. doi: 10.1111/resp.12759. Epub 2016 Mar 19.</citation>
    <PMID>26994409</PMID>
  </reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>September 23, 2018</last_update_submitted>
  <last_update_submitted_qc>September 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Santa Lucia</investigator_affiliation>
    <investigator_full_name>Antonio Tomás Ríos-Cortés</investigator_full_name>
    <investigator_title>Msc Physiotherapist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

